Selling a vet practice: corporate vs private buyer

Selling a veterinary practice is usually the biggest financial decision an owner makes, and most do it once. The choice that shapes everything else is who you sell to: a corporate group backed by private equity, or a private buyer such as an associate or another independent veterinarian. This guide sets out how each path works, what the current market data says about prices and deal structure, and the questions to settle before you talk to anyone.

Vet Rounds has no relationship with any broker, consolidator or lender. Nothing here is legal or tax advice.

The two main paths

Corporate (consolidator) buyers are groups that own many practices and are usually backed by private equity or other institutional investors. They typically price a practice as a multiple of its earnings (EBITDA), pay a large share in cash at closing, and often keep part of the price in equity, retained ownership or seller notes. Most also expect the selling veterinarian to keep working for a set period.

Private buyers are usually an associate who already works at the practice, a nearby independent owner, or a veterinarian looking to buy a first practice. They usually finance the purchase with a bank loan, often an SBA-backed loan, plus their own savings and sometimes a note from the seller. Prices tend to be based on appraised value and on what a lender will finance, rather than on a competitive bidding process.

Neither path is right for everyone. The best choice depends on your practice's size and profitability, your timeline, what you want for your team, and how much risk you are willing to keep after closing.

What the current market data says

Reliable deal data in veterinary medicine is limited, because most transactions are private. The most detailed recent public report comes from broker Ackerman Group, based on its own transactions. Treat its figures as one adviser's data, not the whole market.

According to Ackerman Group's Q2 2026 market update:

The weighted-average multiple for general practices it sold was 13.4x EBITDA in the first half of 2026, up from 12.4x in the second half of 2025. That figure is based on 20 hospitals.
That average is pulled up by large practices. Practices with 5+ DVMs and more than $750,000 in EBITDA averaged 14.7x. All other general practices averaged 11.8x, which Ackerman says has been flat for more than two years.
The overall range was 8x to 16x EBITDA.
Cash at closing averaged 8.7x EBITDA, or 65% of total consideration. The other 35% came as retained ownership, equity in the parent company or seller notes, which pay out over time instead of at closing.
Consolidator acquisitions peaked at about 1,100 practices in 2021 and fell to roughly 350 in each of 2024 and 2025.
Ackerman notes that most corporate buyers require three to five years of post-closing employment from the seller.

The takeaway: if your practice has fewer than five veterinarians, plan around the "other practices" figure, not the headline average. And always compare offers on cash at closing and on the terms of the deferred portion, not just the headline multiple.

Get the business of vet practice in five minutes, every Monday.Free. Unsubscribe any time. We never sell or share your email.

Subscribe free

What a corporate deal typically looks like

The structure matters as much as the price. Before you compare offers, understand each component:

Cash at closing. The money you receive on the day the deal closes, before taxes and fees.
Rollover or retained equity. A share of the price paid in ownership, either in your practice or in the buyer's parent company. Its value depends on the buyer's future performance and on a future sale or recapitalization that you don't control.
Seller notes or earn-outs. Payments over time, sometimes tied to the practice hitting targets after closing.
Employment agreement. How long you must stay, your schedule, your pay, and what happens if you leave early.
Non-compete. How far and how long you're restricted from practicing nearby after you leave.
Real estate. If you own the building, whether the buyer leases it from you and on what terms, or buys it outright.

Ask every buyer to put these in writing in a side-by-side format. Two offers with the same headline multiple can be worth very different amounts.

What a private sale typically looks like

A sale to an associate or another independent veterinarian often looks simpler but takes more planning:

Financing sets the ceiling. Most private buyers borrow. The SBA 7(a) program, a common source of financing for practice purchases, has a maximum loan of $5 million, and changes of ownership are an eligible use (SBA). The lender will want to see that the practice's cash flow can cover the loan payments, which limits what the buyer can pay.
Valuation comes from an appraisal, usually based on the practice's financial history, rather than from competing bids.
Seller financing is common. A seller note for part of the price can bridge the gap between what a buyer can borrow and the agreed price. It also means you carry some risk until it's paid off.
The timeline is longer. Identifying and preparing an associate buyer can take years. Many owners start with a partial sale, selling part of the practice now and the rest later.

The main advantages are control and continuity. You choose the buyer, the practice stays independent, and your team and clients keep a familiar culture. The main trade-offs are typically a lower or slower payout, and the work of finding and preparing a buyer.

Joint ventures and partial sales

There is a middle path. In a joint venture or partial sale, a corporate partner buys a majority or minority stake, and you keep part of the ownership and usually continue running the practice. Ackerman reports this has become the most common strategic question among owners under 60 with practices of fewer than five DVMs (Ackerman Group Q2 2026). Read the governance terms closely. Who decides on hiring, pricing and capital spending matters as much as the percentage you keep.

How to increase your practice's value before you sell

Buyers pay for earnings they believe will continue. A few things typically affect that:

Clean financials. Three years of accurate, accountant-prepared statements, with personal and one-time expenses clearly separated.
Healthy staffing costs. Ackerman describes a seller that spent a year fixing its staffing cost structure before going to market and then received offers from eight buyer groups (Ackerman Group Q2 2026). That's one example, not a rule, but it shows how much profitability shapes the offers you get.
Less dependence on you. Practices where revenue is spread across several veterinarians are lower risk to a buyer than practices where the owner produces most of it.
Stable visits. With national visits flat to falling (the Vetsource/AVMA tracker showed visits down 2.0% over the 12 months to mid-October 2026, per Vetsource Veterinary Analytics), a practice that holds its patient base stands out.
Documented systems. Written processes for scheduling, inventory, pricing and recall make the practice easier to take over.

Questions to answer before you talk to buyers

When do you want to stop practicing, and how much do you want to work until then? This decides whether a three-to-five-year employment agreement works for you.
How much risk do you want to keep after closing? Equity and seller notes can add value, but they aren't cash.
What do you want for your team and clients? If you want the practice to stay independent, start planning a private sale early.
Do you own the real estate? Decide whether you want to keep it as rental income or sell it with the practice.
Who are your advisers? At a minimum, an accountant and a lawyer who have handled veterinary deals. If you hire a broker, ask how they're paid and whether they receive anything from buyers.

FAQ

What multiple of EBITDA do vet practices sell for in 2026?

One broker, Ackerman Group, reported a weighted average of 13.4x EBITDA for the general practices it sold in the first half of 2026. Large practices (5+ DVMs, over $750,000 EBITDA) averaged 14.7x and other general practices averaged 11.8x, from 20 transactions. Your practice's value depends on its own earnings and risk.

Is it better to sell to a corporate buyer or a private buyer?

It depends on your goals. Corporate buyers often pay more cash at closing but usually require you to keep working for several years and may pay part of the price in equity. Private buyers keep the practice independent but are limited by what they can finance.

How much of the price is paid in cash at closing?

In Ackerman Group's first-half 2026 data, cash at closing averaged 8.7x EBITDA, or 65% of total consideration. The rest came as retained ownership, parent-company equity or seller notes.

Can an associate get a loan to buy my practice?

Often, yes. SBA 7(a) loans can be used for changes of ownership, up to a maximum of $5 million. Lenders will look at whether the practice's cash flow can cover the payments.

How long do I have to work after selling to a corporate group?

Ackerman Group says most corporate buyers require three to five years of post-closing employment. Terms vary by buyer and are negotiable.

Want the numbers that move every week? They’re in the Monday brief.Free. Unsubscribe any time. We never sell or share your email.

Subscribe free

Keep reading

Sources

All sources accessed October 16, 2026 (PT). Figures marked calc are Vet Rounds arithmetic on the linked data.

Disclosure: Researched with AI tools. Written, edited and fact-checked by Matthew C. and our editorial team. Nothing here is clinical, legal or tax advice. Spot an error? Email hello@veterinaryrounds.com and we’ll correct it.

Selling your vet practice: corporate vs. private buyer.